Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Thirty Respiratory Limited has 2 pending office actions in Biotechnology & Pharmaceuticals. These matters are distributed among 2 distinct examiners and 2 distinct art units, creating separate examination channels rather than a single point of contact.
SAEED, ALI S is the busiest examiner, with 1 pending matter. Counsel may need coordinated but individualized responses because the portfolio spans multiple examiners and art units.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BECKHARDT, LYNDSEY MARIE | 1 | 27.8% | +48.0% |
| SAEED, ALI S | 1 | 31.6% | +33.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17920099 | METHODS AND COMPOSITIONS FOR TREATING AND COMBATTING TUBERCULOSIS | BECKHARDT, LYNDSEY MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17920099 | METHODS AND COMPOSITIONS FOR TREATING AND COMBATTING TUBERCULOSIS | BECKHARDT, LYNDSEY MARIE | — |
| 17920123 | NITRIC OXIDE OR NITRIC OXIDE RELEASING COMPOSITIONS FOR USE IN TREATING SARS-COV AND SARS-COV-2 | SAEED, ALI S | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| 1616 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17920099 | METHODS AND COMPOSITIONS FOR TREATING AND COMBATTING TUBERCULOSIS | BECKHARDT, LYNDSEY MARIE | 1613 | §103§112 | Final Rejection | — | Pending | Oct 20, 2022 |
| 17920123 | NITRIC OXIDE OR NITRIC OXIDE RELEASING COMPOSITIONS FOR USE IN TREATING SARS-COV AND SARS-COV-2 | SAEED, ALI S | 1616 | §103Other | Non-Final OA | — | Pending | Oct 20, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThirty Respiratory Limited has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Lyndsey Marie Beckhardt has the most, with 1 of Thirty Respiratory Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
